INTRODUCTION
============

Cholecystectomy is one of the most frequently performed abdominal surgery procedures in the United States, with \>750,000 cholecystectomies performed laparoscopically each year.^[@B1],[@B2]^ Laparoscopic cholecystectomy evolved from surgical attempts to improve patient outcomes, including postoperative morbidity, cosmetic results, hospital length of stay, and duration of convalescence.^[@B3]--[@B5]^ Continued attempts to improve these outcomes have led to the development of alternatives to conventional laparoscopic cholecystectomy (CLC), including micro- or mini-laparoscopic cholecystectomy (MLC) and, more recently, single-port cholecystectomy surgery (SPS).^[@B6]^ However, understanding the effect of these emerging techniques on clinical and economic outcomes is critical to guiding practice patterns, clinical guidelines, and payor decisions.

SPS is a technical departure from CLC in that it uses a single, transabdominal incision rather than multiple incisions for trocar insertion.^[@B7],[@B8]^ This procedure is typically performed with several trocars spaced closely together or with a multi-instrument port.^[@B7]--[@B9]^

MLC is performed by use of percutaneous instrumentation or trocars that are significantly smaller in size than those used in conventional laparoscopic procedures. The procedure was primarily developed to reduce incisional pain. Studies have reported improvements in cosmetic outcome, pulmonary function, and overall satisfaction.^[@B10]--[@B14]^ One small study did report that up to 38% of patients (5 of 13) required conversion from MLC to CLC.^[@B10]^

The purpose of this article is a cost comparison of cholecystectomy approaches including conventional, single-port, and mini-laparoscopic surgeries. We performed our analysis using the Premier Hospital Database as a source of cost from the hospital perspective.

METHODS
=======

A protocol describing the analysis objectives, criteria for patient selection, data elements of interest, and statistical methods was submitted to the New England Institutional Review Board, and exemption was obtained (No. 11--240).

Data Source
-----------

The Premier Hospital Database, which contains clinical and utilization information on patients receiving care in 442 hospitals and ambulatory surgery centers across the United States during the period of interest, was used. Specifically, this database contains complete patient billing, hospital cost, and coding histories from more than 25 million inpatient discharges and 175 million hospital outpatient visits.^[@B15]^ Data for 2009 through the second quarter of 2010 were used and anonymized with regard to patient identifiers.

Patients and Procedures
-----------------------

Eligible patients were those aged ≥18 years undergoing an outpatient laparoscopic cholecystectomy. *International Classification of Diseases, Ninth Revision* and Current Procedural Terminology codes for identifying the laparoscopic cholecystectomy, diagnosis codes for identifying patient comorbid conditions, and all adverse events are listed in Appendices A, B, and C, respectively.

Eligible patients with procedure codes identifying a laparoscopic cholecystectomy were then subdivided into 3 mutually exclusive groups: CLC, SPS, or MLC. Hospital charge descriptions for the surgical tools used were text mined to identify SPS procedures. The distinction between MLC and CLC was based on the size of the surgical instrument. MLC was defined by records of no SPS products identified in the charge master descriptions, record of at least 1 product \<5 mm used; not more than 1 product \>5 mm used, and any other products identified equaled 5 mm. Procedures that were not identified as SPS or MLC were considered CLC procedures.

Statistical Analyses
--------------------

Initial counts, percentages, means, and standard deviations for demographics, comorbid conditions, hospital characteristics, safety, and cost outcomes were summarized for CLC, SPS, and MLC by use of descriptive statistics for patients in the outpatient setting. Safety outcomes of interest were selected from adverse events occurring during or up to 30 days after surgery. Cost outcomes were total hospital costs per patient, both fixed and variable.

Because the sample size for the SPS group was very limited in the inpatient setting, univariate and multivariable analyses were performed on outpatient procedures only. Furthermore, by examining patients in the outpatient setting only, it was possible to analyze a more homogeneous patient population.

Multivariable logistic regression analyses were run for binary outcomes, such as adverse events. Ordinary least squares regressions were used for the continuous outcome of hospital costs. For all models, the following explanatory variables were included: age, sex, race, marital status, insurance type, comorbid conditions (e.g., diabetes), census region of the hospital, rural versus urban hospitals, teaching versus nonteaching hospitals, and number of hospital beds. By use of these explanatory variables, multivariable models were estimated to isolate the effects of SPS versus CLC, SPS versus MLC, and MLC versus CLC on hospital costs. To eliminate cost outliers, both the upper 0.5% and lower 0.5% of costs were set to missing values. In addition to the trimming of outliers, a natural-log transformation of the costs was used as the dependent variable in multivariate models. Smearing estimates were then used to avoid the introduction of bias when we converted back to the untransformed dollar scale.^[@B16]^ All analyses were performed with SAS software, version 9.2 (SAS Institute, Cary, NC, USA).

RESULTS
=======

There were a total of 193,014 eligible laparoscopic cholecystectomy procedures identified in the database from the period from the first quarter of 2009 through the second quarter of 2010. A patient attrition diagram is shown in **[Figure 1](#F1){ref-type="fig"}**. The majority of all procedures (59%, 116,823 of 196,628) were performed in the outpatient setting, with 98% (114,356) of these patients undergoing a CLC. For the remaining 2% of outpatient procedures (2,467), 527 SPS procedures and 1,940 MLC procedures were identified. As summarized in **[Table 1](#T1){ref-type="table"}**, characteristics of eligible outpatient procedures show that there were substantially more women than men, with rates for both dropping off after age 50 years. Regarding insurance, more patients had managed care than government or other sources of insurance. In the outpatient setting, the 3 procedure groups (SPS, MLC, and CLC) appear to be very well balanced overall in terms of patient demographics.

![Patient attrition is shown from all data from the first quarter (Q1) of 2009 to the second quarter (Q2) of 2010 to the subset used in our analysis. The analysis included patients with *International Classification of Diseases, Ninth Revision* (ICD-9) code 51.23 or Current Procedural Terminology (CPT) code 47562, 47563, or 47564 whose gender was known, who were aged ≥18 years, and who underwent outpatient visits.](jls0011329720001){#F1}

###### 

Patient Characteristics

                         SPS (n = 527) (%)   MLC (n = 1,940) (%)   CLC (n = 114,356) (%)
  ---------------------- ------------------- --------------------- -----------------------
  Age                                                              
      18--40 yr          282 (53.5)          751 (38.7)            43,452 (38.0)
      41--50 yr          113 (21.4)          411 (21.2)            23,364 (20.4)
      51--60 yr          76 (14.4)           361 (18.6)            21,703 (19.0)
      61--70 yr          35 (6.6)            258 (13.3)            15,413 (13.5)
      71--80 yr          17 (3.2)            124 (6.4)             8,068 (7.1)
      \>80 yr            4 (0.8)             35 (1.8)              2,356 (2.1)
  Gender                                                           
      Female             445 (84.4)          1,443 (74.4)          86,757 (75.9)
      Male               82 (15.6)           497 (25.6)            27,599 (24.1)
  Insurance                                                        
      Government         108 (20.5)          582 (30.0)            35,410 (31.0)
      Managed care       331 (62.8)          1,090 (56.2)          56,228 (49.2)
      Other              88 (16.7)           268 (13.8)            22,718 (19.9)
  Race                                                             
      White              418 (79.3)          1,318 (67.9)          81,096 (70.9)
      African American   22 (4.2)            109 (5.6)             8,358 (7.3)
      Hispanic           27 (5.1)            172 (8.9)             7,509 (6.6)
      Other              60 (11.4)           341 (17.6)            17,307 (15.1)
      Invalid code       0 (0.0)             0 (0.0)               86 (0.1)

The distribution of patient comorbidities is shown in **[Table 2](#T2){ref-type="table"}** and suggests a lower percentage of comorbidities overall in the SPS population, with the rates of many of the conditions as low as half of the rates in the other cohorts. Hypertension was the most common comorbid condition across all 3 groups.

###### 

Comorbid Conditions

                                                            SPS (n = 527) (%)   MLC (n = 1,940) (%)   CLC (n = 114,356) (%)
  --------------------------------------------------------- ------------------- --------------------- -----------------------
  Cardiomyopathy                                            2 (0.4)             15 (0.8)              778 (0.7)
  Cerebrovascular accident                                  1 (0.2)             11 (0.6)              548 (0.5)
  Chronic obstructive pulmonary disease                     14 (2.7)            73 (3.8)              4,232 (3.7)
  Diabetes                                                  23 (4.4)            170 (8.8)             9,904 (8.7)
  Ischemic heart disease, including myocardial infarction   17 (3.2)            131 (6.8)             7,108 (6.2)
  Hypertensive heart disease without heart failure          2 (0.4)             8 (0.4)               566 (0.5)
  Heart failure                                             8 (1.5)             40 (2.1)              2,145 (1.9)
  Hypertension                                              86 (16.3)           414 (21.3)            24,664 (21.6)
  Chronic liver disease/disorders                           14 (2.7)            75 (3.9)              6,425 (5.6)
  Transient ischemic attack                                 1 (0.2)             16 (0.8)              754 (0.7)

Unadjusted Analysis
-------------------

The cholecystectomies studied were performed in 428 hospitals. Most procedures, as well as most patients, derived from urban, nonteaching, moderate- to large-sized hospitals in the South.^[@B15]^ As noted earlier for the overall patient population, hospital characteristics were well balanced across all 3 surgical cohorts (CLC, MLC, and SPS).

All adverse events are reported in **[Table 3](#T3){ref-type="table"}**. Events are subdivided into 5 categories: procedure related, systemic, other events, death, and bleeding. The most common complications were in the category of other events and included abdominal rigidity/tenderness, digestive system complications, gastroparesis paralytic ileus, nausea and vomiting, operative complications, and peritonitis. The overall adverse event rate was higher for SPS (12%) than for MLC (6%) and CLC (6%), with most of the events in all 3 groups falling into the "other events" category. The procedure-related systemic events, death and bleeding, were very infrequent (\<0.5%) for all 3 groups.

###### 

Adverse Events

                                       SPS (n = 527) (%)   MLC (n = 1,940) (%)   CLC (n = 114,356) (%)
  ------------------------------------ ------------------- --------------------- -----------------------
  Procedure related                                                              
      Bile duct fistula                0 (0.0)             0 (0.0)               7 (0.0)
      Bile duct obstruction            2 (0.4)             2 (0.1)               195 (0.2)
      Bile duct perforation            0 (0.0)             0 (0.0)               6 (0.0)
  Systemic adverse events                                                        
      Cerebrovascular accident         0 (0.0)             1 (0.1)               43 (0.0)
      Acute myocardial infarction      0 (0.0)             2 (0.1)               37 (0.0)
      Transient ischemic attack        0 (0.0)             2 (0.1)               46 (0.0)
      Other embolism                   0 (0.0)             3 (0.2)               120 (0.1)
      Pneumothorax                     0 (0.0)             0 (0.0)               16 (0.0)
      Pulmonary embolism               1 (0.2)             3 (0.2)               95 (0.1)
  Other adverse events                                                           
      Abdominal rigidity/tenderness    0 (0.0)             0 (0.0)               114 (0.1)
      Digestive system complications   8 (1.5)             15 (0.8)              735 (0.6)
      Gastroparesis paralytic ileus    4 (0.8)             7 (0.4)               438 (0.4)
      Nausea and vomiting              45 (8.5)            86 (4.4)              4,874 (4.3)
      Operative complication           19 (3.6)            30 (1.6)              2,006 (1.8)
      Peritonitis (not specified)      1 (0.2)             3 (0.2)               103 (0.1)
  Death                                                                          
      Death during procedure           0 (0.0)             0 (0.0)               2 (0.0)
      Death after procedure            0 (0.0)             2 (0.1)               35 (0.0)
  Hemorrhage/bleeding                                                            
      Minor bleeding                   0 (0.0)             0 (0.0)               9 (0.0)
      Major bleeding                   0 (0.0)             0 (0.0)               20 (0.0)
  Any one or more adverse event        **62 (11.8)**       **123 (6.3)**         **7,307 (6.4)**

**[Table 4](#T4){ref-type="table"}** shows the unadjusted means and medians for hospital costs, as well as median surgery time, for each group. In the outpatient setting, CLC (median, \$3,600.37) costs slightly more than MLC (median, \$3,357.01) but less than SPS (median, \$4,367.93). It is essential to adjust for a number of potential confounders in multivariable regression analyses, including patient demographics, comorbid conditions, and hospital characteristics.

###### 

Unadjusted Utilization and Cost Outcomes

                                                    SPS (n = 527)   MLC (n = 1,940)   CLC (n = 114,356)
  ------------------------------------------------- --------------- ----------------- -------------------
  Surgery time (median, h)                          1.60            1.26              1.35
  Anesthesia time (median, h)                       1.57            1.50              1.47
  No. of readmissions (30 days after surgery) (%)   20 (3.8)        71 (3.7)          3,200 (2.8)
  Total hospital costs (\$)                                                           
      Median                                        4,367.93        3,357.01          3,600.37
      Mean                                          4,573.74        3,814.35          3,964.67
      SD                                            1,664.17        1,992.26          1,967.81

Adjusted Analysis
-----------------

The results of adjusted analyses of costs and complication rates are shown in **[Table 5](#T5){ref-type="table"}**. After we adjusted for the aforementioned variables, adjusted mean hospital costs remained significantly higher (*P* \< .0001) for SPS versus MLC (\$4,680.40 vs \$3,846.19) and SPS versus CLC (\$5,313.96 vs \$4,350.29). When we compared MLC versus CLC, cost differences were lower but still significant (*P* \< .0001), with MLC at \$4,137.23 versus CLC at \$4,349.06.

###### 

Multivariable Cost and Adverse Event Findings^[a](#TF5-1){ref-type="table-fn"}^

                                                    LS^[b](#TF5-2){ref-type="table-fn"}^ Mean   95% CI^[b](#TF5-2){ref-type="table-fn"}^ for LS Mean   OR^[b](#TF5-2){ref-type="table-fn"}^   95% CI for OR   *P* Value
  ------------------------------------------------- ------------------------------------------- ------------------------------------------------------ -------------------------------------- --------------- -----------
  SPS/MLC outpatients (n = 2,535)                                                                                                                                                                             
          Total hospital costs (\$)                                                                                                                                                                           
              SPS                                   \$4,680.40                                  \$4,480.96--\$4,888.73                                                                                        \< .0001
              MLC                                   \$3,846.19                                  \$3,722.38--\$3,974.11                                                                                        
          Adverse events (any adverse event/none)                                                                                                                                                             
              SPS vs MLC                                                                                                                               1.92                                   1.38--2.68      .0001
  SPS/CLC outpatients (n = 114,883)                                                                                                                                                                           
          Total hospital costs (\$)                                                                                                                                                                           
              SPS                                   \$5,313.96                                  \$5,119.09--\$5,516.25                                                                                        \< .0001
              CLC                                   \$4,350.29                                  \$4,276.75--\$4,425.09                                                                                        
          Adverse events (any adverse event/none)                                                                                                                                                             
              SPS vs CLC                                                                                                                               1.80                                   1.37--2.35      \< .0001
  MLC/CLC outpatients (n = 116,296)                                                                                                                                                                           
          Total hospital costs (\$)                                                                                                                                                                           
              MLC                                   \$4,137.23                                  \$4,037.97--\$4,238.93                                                                                        \< .0001
              CLC                                   \$4,349.06                                  \$4,275.54--\$4,423.85                                                                                        
          Adverse events (any adverse event/none)                                                                                                                                                             
              MLC vs CLC                                                                                                                               1.01                                   0.84--1.21      .9333

All models are adjusted for patient demographics, comorbid conditions, patient severity, and hospital characteristics.

CI=confidence interval; LS=least square; OR=odds ratio.

Results of the multivariable logistic regressions for the likelihood of patients having an adverse event showed significant (*P* \< .0001) odds ratios of 1.92 (95% confidence interval, 1.38--2.68) for SPS compared with MLC and 1.80 (95% confidence interval, 1.37--2.35) for SPS compared with CLC. However, when MLC was compared with CLC, the difference was not significant.

DISCUSSION
==========

This retrospective analysis of a large, nationally representative database of hospitals and procedures found that patients undergoing SPS had higher adverse event rates than those undergoing MLC or CLC. The analysis also showed that SPS was associated with higher adjusted hospital outpatient costs than CLC but that MLC, when performed in this setting, was the least expensive. These findings are somewhat consistent with a recent review of SPS, which also raised concerns about the safety of the procedure, and a recent meta-analysis of primarily MLC procedures, which found similar rates of adverse events compared with patients undergoing CLC.^[@B17],[@B18]^

Clinical Implications
---------------------

Innovations in the surgical approach to performing cholecystectomy represent an important potential pathway to improving patient outcomes. The development and diffusion of laparoscopic cholecystectomy to the United States that began more than 20 years ago heralded a reduction in postoperative mortality rates and days of convalescence for patients who would have otherwise been treated with open cholecystectomy.^[@B2]^ This pattern of innovation continues with both SPS and MLC. However, continued improvements in patient outcomes can only be ensured with careful attention to the comparative effectiveness of these procedures relative to CLC, which constitutes most cholecystectomies currently performed in developed countries.^[@B19]^

Adverse event rates in patients undergoing cholecystectomy in outpatient hospital centers were highest in patients treated with SPS compared with MLC and CLC and were comparable between patients treated with MLC and those treated with CLC. This difference appears to be driven by higher rates of bile duct obstruction, digestive system complications, gastroparesis, paralytic ileus, postoperative nausea and vomiting, and operative complications in the SPS population. The incidence of serious adverse events, including bile duct injury, thromboembolic events (including stroke and myocardial infarction), and hemorrhage, was low across all procedures and did not appear to be substantially different in patients undergoing SPS.

Economic Implications
---------------------

Adjusted hospital outpatient costs were highest in patients undergoing SPS: SPS cost 18% more than MLC and 18% more than CLC, with a difference of \$834 and \$964, respectively **([Table 5](#T5){ref-type="table"})**. The analyses also showed that MLC was associated with the lowest hospital costs. It is likely that the differences in adverse event rates detailed earlier contributed to the cost differences.

Because otherwise healthy patients with reliable home support can leave the hospital within 6 hours of undergoing cholecystectomy, outpatient models of cholecystectomy are increasingly used.^[@B20]^ The sources of variation in costs of cholecystectomy procedures performed in an outpatient setting should be explored further in future studies, but these findings of statistically significant differences between the cost of SPS and the cost of MLC or CLC may have important implications with regard to the cost of the procedure to the hospital or outpatient facility. With approximately 750,000 laparoscopic cholecystectomies performed in the United States each year, any differences in procedure-related costs or savings could be significant and realizable.^[@B1],[@B2]^

Limitations
-----------

This analysis was limited by the lack of more detailed information about patients and procedures. For instance, it would have been of interest to examine the influence of additional patient characteristics, such as weight or body mass index, and more procedure-related details. In the future, this may be possible as clinically rich datasets become available from greater use of electronic medical records in hospital settings, thereby facilitating analyses in these directions.

The analyses of adverse event rates and the specific types of complications constituting these rates in patients undergoing SPS were also limited by a small sample size, particularly compared with the number of patients in the database who underwent MLC or CLC. Surgeon experience is a well-established predictor of the overall incidence of laparoscopic complications, and we were unable to adjust for this important variable.^[@B21],[@B22]^ The available data will likely become more robust over time as procedure volume increases.

Even without access to the additional clinical detail available in electronic medical records, the Premier Hospital Database provides a strong basis for this analysis, given the very large numbers of patients and procedures that it provides, as well as the nationwide scope it represents.^[@B15]^ Thus the cost of each procedure was based on costs across the Premier network. This analysis found MLC to have a statistically lower cost to the hospital in comparison with CLC. The reasons for these differences were not ascertained, and further study to understand these differences would be of interest.

CONCLUSION
==========

The analysis of a large, nationally representative hospital claims database provides evidence that, in the outpatient setting, SPS costs approximately 18% more than MLC and CLC. Mini-laparoscopic surgery costs approximately 5% less than traditional laparoscopy. Although additional studies may be useful, these findings could help shape practice patterns, treatment guidelines, and payor policy in the management of patients requiring cholecystectomy.

###### 

Procedure Codes for Laparoscopic Cholecystectomy

                                                   Description
  ------------------------------------------------ --------------------------------------------------------------
  ICD-9^[a](#TFAU1-1){ref-type="table-fn"}^ code   
      51.23                                        Laparoscopic cholecystectomy
      51.24                                        Laparoscopic partial cholecystectomy
  CPT^[a](#TFAU1-1){ref-type="table-fn"}^ code     
      47562                                        Laparoscopic cholecystectomy
      47563                                        Laparoscopic cholecystectomy with cholangiography
      47564                                        Laparoscopic cholecystectomy with exploration of common duct

CPT=Current Procedural Terminology; ICD-9=*International Classification of Diseases, Ninth Revision*.

###### 

Diagnosis Codes for Comorbid Conditions

  Event                                                     ICD-9^[a](#TFBU1-1){ref-type="table-fn"}^ Code                                      Description
  --------------------------------------------------------- ----------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------
  Transient ischemic attack                                 435.8                                                                               Other specified transient cerebral ischemia
                                                            435.9                                                                               Unspecified transient cerebral ischemia
  Cerebrovascular accident                                  430                                                                                 Subarachnoid hemorrhage
                                                            431                                                                                 Intracerebral hemorrhage
                                                            432                                                                                 Nontraumatic extradural hemorrhage
                                                            432.1                                                                               Subdural hemorrhage
                                                            432.9                                                                               Unspecified intracranial hemorrhage
                                                            433.01                                                                              Occlusion and stenosis, basilar artery, with cerebral infarction
                                                            433.11                                                                              Occlusion and stenosis, carotid artery, with cerebral infarction
                                                            433.21                                                                              Occlusion and stenosis, vertebral artery, with cerebral infarction
                                                            433.31                                                                              Occlusion and stenosis, multiple and bilateral precerebral arteries, with cerebral infarction
                                                            433.81                                                                              Occlusion and stenosis, other specified precerebral artery, with cerebral infarction
                                                            433.91                                                                              Occlusion and stenosis, unspecified precerebral artery, with cerebral infarction
                                                            434.01                                                                              Cerebral thrombosis, with cerebral infarction
                                                            434.11                                                                              Cerebral embolism, with cerebral infarction
                                                            434.91                                                                              Cerebral artery occlusion, unspecified, with cerebral infarction
                                                            997.02                                                                              Iatrogenic cerebrovascular infarction or hemorrhage
  Diabetes                                                  249                                                                                 Secondary diabetes mellitus
                                                            249.01                                                                              Secondary diabetes mellitus without mention of complication, uncontrolled
                                                            249.1                                                                               Secondary diabetes mellitus with ketoacidosis
                                                            249.11                                                                              Secondary diabetes mellitus with ketoacidosis, uncontrolled
                                                            249.2                                                                               Secondary diabetes mellitus with hyperosmolarity
                                                            249.21                                                                              Secondary diabetes mellitus with hyperosmolarity, uncontrolled
                                                            249.3                                                                               Secondary diabetes mellitus with other coma
                                                            249.31                                                                              Secondary diabetes mellitus with other coma, uncontrolled
                                                            249.4                                                                               Secondary diabetes mellitus with renal manifestations
                                                            249.41                                                                              Secondary diabetes mellitus with renal manifestations, uncontrolled
                                                            249.5                                                                               Secondary diabetes mellitus with ophthalmic manifestations
                                                            249.51                                                                              Secondary diabetes mellitus with ophthalmic manifestations, uncontrolled
                                                            249.6                                                                               Secondary diabetes mellitus with neurological manifestations
                                                            249.61                                                                              Secondary diabetes mellitus with neurological manifestations, uncontrolled
                                                            249.7                                                                               Secondary diabetes mellitus with peripheral circulatory disorders
                                                            249.71                                                                              Secondary diabetes mellitus with peripheral circulatory disorders, uncontrolled
                                                            249.8                                                                               Secondary diabetes mellitus with other specified manifestations
                                                            249.81                                                                              Secondary diabetes mellitus with other specified manifestations, uncontrolled
                                                            249.9                                                                               Secondary diabetes mellitus with unspecified complication
                                                            249.91                                                                              Secondary diabetes mellitus with unspecified complication, uncontrolled
                                                            250                                                                                 Diabetes mellitus
                                                            250.01                                                                              Diabetes mellitus without mention of complication, type I (juvenile type), not stated as uncontrolled
                                                            250.02                                                                              Diabetes mellitus without mention of complication, type II or unspecified type, uncontrolled
                                                            250.03                                                                              Diabetes mellitus without mention of complication, type I (juvenile type), uncontrolled
                                                            250.1                                                                               Diabetes with ketoacidosis, type II or unspecified type, not stated as uncontrolled
                                                            250.11                                                                              Diabetes with ketoacidosis, type I (juvenile type), not stated as uncontrolled
                                                            250.12                                                                              Diabetes with ketoacidosis, type II or unspecified type, uncontrolled
                                                            250.13                                                                              Diabetes with ketoacidosis, type I (juvenile type), uncontrolled
                                                            250.2                                                                               Diabetes with hyperosmolarity
                                                            250.21                                                                              Diabetes with hyperosmolarity, type I (juvenile type), not stated as uncontrolled
                                                            250.22                                                                              Diabetes with hyperosmolarity, type II or unspecified type, uncontrolled
                                                            250.23                                                                              Diabetes with hyperosmolarity, type I (juvenile type), uncontrolled
                                                            250.3                                                                               Diabetes with other coma
                                                            250.31                                                                              Diabetes with other coma, type I (juvenile type), not stated as uncontrolled
                                                            250.32                                                                              Diabetes with other coma, type II or unspecified type, uncontrolled
                                                            250.33                                                                              Diabetes with other coma, type I (juvenile type), uncontrolled
                                                            250.4                                                                               Diabetes with renal manifestations
                                                            250.41                                                                              Diabetes with renal manifestations, type I (juvenile type), not stated as uncontrolled
                                                            250.42                                                                              Diabetes with renal manifestations, type II or unspecified type, uncontrolled
                                                            250.43                                                                              Diabetes with renal manifestations, type I (juvenile type), uncontrolled
                                                            250.5                                                                               Diabetes with ophthalmic manifestations
                                                            250.51                                                                              Diabetes with ophthalmic manifestations, type I (juvenile type), not stated as uncontrolled
                                                            250.52                                                                              Diabetes with ophthalmic manifestations, type II or unspecified type, uncontrolled
                                                            250.53                                                                              Diabetes with ophthalmic manifestations, type I (juvenile type), uncontrolled
                                                            250.6                                                                               Diabetes with neurological manifestations, type II or unspecified type, not stated as uncontrolled
                                                            250.61                                                                              Diabetes with neurological manifestations, type I (juvenile type), not stated as uncontrolled
                                                            250.62                                                                              Diabetes with neurological manifestations, type II or unspecified type, uncontrolled
                                                            250.63                                                                              Diabetes with neurological manifestations, type I (juvenile type), uncontrolled
                                                            250.7                                                                               Diabetes with peripheral circulatory disorders
                                                            250.71                                                                              Diabetes with peripheral circulatory disorders, type I (juvenile type), not stated as uncontrolled
                                                            250.72                                                                              Diabetes with peripheral circulatory disorders, type II or unspecified type, uncontrolled
                                                            250.73                                                                              Diabetes with peripheral circulatory disorders, type I (juvenile type), uncontrolled
                                                            250.8                                                                               Diabetes with other specified manifestations
                                                            250.81                                                                              Diabetes with other specified manifestations, type I (juvenile type), not stated as uncontrolled
                                                            250.82                                                                              Diabetes with other specified manifestations, type II or unspecified type, uncontrolled
                                                            250.83                                                                              Diabetes with other specified manifestations, type I (juvenile type), uncontrolled
                                                            250.9                                                                               Diabetes with unspecified complication
                                                            250.91                                                                              Diabetes with unspecified complication, type I (juvenile type), not stated as uncontrolled
                                                            250.92                                                                              Diabetes with unspecified complication, type II or unspecified type, uncontrolled
                                                            250.93                                                                              Diabetes with unspecified complication, type I (juvenile type), uncontrolled
  Chronic obstructive pulmonary disease                     491.1                                                                               Mucopurulent chronic bronchitis
  491.2                                                     Obstructive chronic bronchitis                                                      
                                                            491.21                                                                              Obstructive chronic bronchitis with (acute) exacerbation
                                                            491.22                                                                              Obstructive chronic bronchitis with acute bronchitis
                                                            491.8                                                                               Other chronic bronchitis
                                                            491.9                                                                               Unspecified chronic bronchitis
                                                            492                                                                                 Emphysema
                                                            492.0                                                                               Emphysematous bleb
                                                            492.8                                                                               Other emphysema
                                                            493.2                                                                               Chronic obstructive asthma
                                                            493.20                                                                              Chronic obstructive asthma, unspecified
                                                            493.21                                                                              Chronic obstructive asthma with status asthmaticus
                                                            493.22                                                                              Chronic obstructive asthma with (acute) exacerbation
                                                            494                                                                                 Bronchiectasis
                                                            494.0                                                                               Bronchiectasis without acute exacerbation
                                                            494.1                                                                               Bronchiectasis with acute exacerbation
                                                            496                                                                                 Chronic airway obstruction, not elsewhere classified
  Chronic liver disease/disorders                           571.x                                                                               Chronic liver disease and cirrhosis
  571.4x                                                    Chronic hepatitis                                                                   
                                                            572.x                                                                               Liver abscess and sequelae of chronic liver disease
                                                            573.x                                                                               Other disorders of liver
  Hypertension                                              401                                                                                 Essential hypertension
                                                            401.0                                                                               Malignant essential hypertension
                                                            401.1                                                                               Benign essential hypertension
                                                            401.9                                                                               Unspecified essential hypertension
                                                            405                                                                                 Secondary hypertension
                                                            405.0                                                                               Malignant secondary hypertension
                                                            405.01                                                                              Malignant renovascular hypertension
                                                            405.09                                                                              Other malignant secondary hypertension
                                                            405.1                                                                               Benign secondary hypertension
                                                            405.11                                                                              Benign renovascular hypertension
                                                            405.19                                                                              Other benign secondary hypertension
                                                            405.9                                                                               Unspecified secondary hypertension
                                                            405.91                                                                              Unspecified renovascular hypertension
                                                            405.99                                                                              Other unspecified secondary hypertension
  Ischemic heart disease, including myocardial infarction   410                                                                                 Acute myocardial infarction
  410.0                                                     Acute myocardial infarction of anterolateral wall                                   
  410.01                                                    Acute myocardial infarction of anterolateral wall, initial episode of care          
                                                            410.02                                                                              Acute myocardial infarction of anterolateral wall, subsequent episode of care
                                                            410.1                                                                               Acute myocardial infarction of other anterior wall
                                                            410.10                                                                              Acute myocardial infarction of other anterior wall, episode of care unspecified
                                                            410.11                                                                              Acute myocardial infarction of other anterior wall, initial episode of care
                                                            410.12                                                                              Acute myocardial infarction of other anterior wall, subsequent episode of care
                                                            410.2                                                                               Acute myocardial infarction of inferolateral wall
                                                            410.20                                                                              Acute myocardial infarction of inferolateral wall, episode of care unspecified
                                                            410.21                                                                              Acute myocardial infarction of inferolateral wall, initial episode of care
                                                            410.22                                                                              Acute myocardial infarction of inferolateral wall, subsequent episode of care
                                                            410.3                                                                               Acute myocardial infarction of inferoposterior wall
                                                            410.30                                                                              Acute myocardial infarction of inferoposterior wall, episode of care unspecified
                                                            410.31                                                                              Acute myocardial infarction of inferoposterior wall, initial episode of care
                                                            410.32                                                                              Acute myocardial infarction of inferoposterior wall, subsequent episode of care
                                                            410.4                                                                               Acute myocardial infarction of other inferior wall
                                                            410.40                                                                              Acute myocardial infarction of other inferior wall, episode of care unspecified
                                                            410.41                                                                              Acute myocardial infarction of other inferior wall, initial episode of care
                                                            410.42                                                                              Acute myocardial infarction of other inferior wall, subsequent episode of care
                                                            410.5                                                                               Acute myocardial infarction of other lateral wall
                                                            410.50                                                                              Acute myocardial infarction of other lateral wall, episode of care unspecified
                                                            410.51                                                                              Acute myocardial infarction of other lateral wall, initial episode of care
                                                            410.52                                                                              Acute myocardial infarction of other lateral wall, subsequent episode of care
                                                            410.6                                                                               Acute myocardial infarction of posterior wall infarction
                                                            410.61                                                                              Acute posterior wall infarction, initial episode of care
                                                            410.62                                                                              Acute posterior wall infarction, subsequent episode of care
                                                            410.7                                                                               Subendocardial infarction
                                                            410.70                                                                              Subendocardial infarction, episode of care unspecified
                                                            410.71                                                                              Subendocardial infarction, initial episode of care
  410.72                                                    Subendocardial infarction, subsequent episode of care                               
  410.8                                                     Acute myocardial infarction of other specified sites                                
  410.80                                                    Acute myocardial infarction of other specified sites, episode of care unspecified   
                                                            410.81                                                                              Acute myocardial infarction of other specified sites, initial episode of care
                                                            410.82                                                                              Acute myocardial infarction of other specified sites, subsequent episode of care
                                                            410.9                                                                               Acute myocardial infarction of unspecified site
                                                            410.90                                                                              Acute myocardial infarction of unspecified site, episode of care unspecified
                                                            410.91                                                                              Acute myocardial infarction of unspecified site, initial episode of care
                                                            410.92                                                                              Acute myocardial infarction of unspecified site, subsequent episode of care
                                                            411                                                                                 Other acute and subacute forms of ischemic heart disease
                                                            411.0                                                                               Postmyocardial infarction syndrome
                                                            411.1                                                                               Intermediate coronary syndrome
                                                            411.8                                                                               Other acute and subacute forms of ischemic heart disease
                                                            411.81                                                                              Acute coronary occlusion without myocardial infarction
                                                            411.89                                                                              Other acute and subacute forms of ischemic heart disease, other
                                                            412                                                                                 Old myocardial infarction
                                                            413                                                                                 Angina pectoris
                                                            413.0                                                                               Angina decubitus
                                                            413.1                                                                               Prinzmetal angina
                                                            413.9                                                                               Other and unspecified angina pectoris
                                                            414                                                                                 Other forms of chronic ischemic heart disease
                                                            414.0                                                                               Coronary atherosclerosis
                                                            414.00                                                                              Coronary atherosclerosis of unspecified type of vessel, native or graft
                                                            414.01                                                                              Coronary atherosclerosis of native coronary artery
                                                            414.02                                                                              Coronary atherosclerosis of autologous vein bypass graft
                                                            414.03                                                                              Coronary atherosclerosis of nonautologous biological bypass graft
                                                            414.04                                                                              Coronary atherosclerosis of artery bypass graft
                                                            414.05                                                                              Coronary atherosclerosis of unspecified bypass graft
                                                            414.06                                                                              Coronary atherosclerosis of native coronary artery of transplanted heart
                                                            414.07                                                                              Coronary atherosclerosis of bypass graft transplanted heart
                                                            414.1                                                                               Aneurysm and dissection of heart
                                                            414.10                                                                              Aneurysm of heart (wall)
                                                            414.11                                                                              Aneurysm of coronary vessels
  414.12                                                    Dissection of coronary artery                                                       
  414.19                                                    Other aneurysm of heart                                                             
  414.2                                                     Chronic total occlusion of coronary artery                                          
                                                            414.3                                                                               Coronary atherosclerosis due to lipid rich plaque
                                                            414.8                                                                               Other specified forms of chronic ischemic heart disease
                                                            414.9                                                                               Chronic ischemic heart disease, unspecified
  Heart failure                                             398.91                                                                              Rheumatic heart failure (congestive)
                                                            402.01                                                                              Benign hypertensive heart disease without heart failure
                                                            402.11                                                                              Benign hypertensive heart disease with heart failure
                                                            402.91                                                                              Unspecified hypertensive heart disease with heart failure
                                                            404.01                                                                              Hypertensive heart and chronic kidney disease, malignant, with heart failure and with chronic kidney disease stage I through stage IV, or unspecified
                                                            404.03                                                                              Hypertensive heart and chronic kidney disease, malignant, with heart failure and with chronic kidney disease stage V or end stage renal disease
                                                            404.11                                                                              Hypertensive heart and chronic kidney disease, benign, with heart failure and with chronic kidney disease stage I through stage IV, or unspecified
                                                            404.13                                                                              Hypertensive heart and chronic kidney disease, benign, with heart failure and chronic kidney disease stage V or end stage renal disease
                                                            404.91                                                                              Hypertensive heart and chronic kidney disease, unspecified, with heart failure and with chronic kidney disease stage I through stage IV, or unspecified
                                                            404.93                                                                              Hypertensive heart and chronic kidney disease, unspecified, with heart failure and chronic kidney disease stage V or end stage renal disease
                                                            428                                                                                 Heart failure
                                                            428.0                                                                               Congestive heart failure, unspecified
                                                            428.1                                                                               Left heart failure
                                                            428.2                                                                               Systolic heart failure
                                                            428.21                                                                              Acute systolic heart failure
                                                            428.22                                                                              Chronic systolic heart failure
                                                            428.23                                                                              Acute on chronic systolic heart failure
                                                            428.3                                                                               Diastolic heart failure
                                                            428.31                                                                              Acute diastolic heart failure
                                                            428.32                                                                              Chronic diastolic heart failure
                                                            428.33                                                                              Acute on chronic diastolic heart failure
                                                            428.4                                                                               Combined systolic and diastolic heart failure
                                                            428.41                                                                              Acute combined systolic and diastolic heart failure
                                                            428.42                                                                              Chronic combined systolic and diastolic heart failure
                                                            428.43                                                                              Acute on chronic combined systolic and diastolic heart failure
                                                            428.9                                                                               Heart failure, unspecified
  Cardiomyopathy                                            425                                                                                 Cardiomyopathy
                                                            425.0                                                                               Endomyocardial fibrosis
                                                            425.1                                                                               Hypertrophic cardiomyopathy
                                                            425.2                                                                               Obscure cardiomyopathy of Africa
                                                            425.3                                                                               Endocardial fibroelastosis
                                                            425.4                                                                               Other primary cardiomyopathies
                                                            425.5                                                                               Alcoholic cardiomyopathy
                                                            425.7                                                                               Nutritional and metabolic cardiomyopathy
                                                            425.8                                                                               Cardiomyopathy in other diseases classified elsewhere
                                                            425.9                                                                               Secondary cardiomyopathy, unspecified
  Hypertensive heart disease without heart failure          402                                                                                 Hypertensive heart disease
  402.0                                                     Malignant hypertensive heart disease                                                
                                                            402.1                                                                               Benign hypertensive heart disease
                                                            402.10                                                                              Benign hypertensive heart disease without heart failure
                                                            402.9                                                                               Unspecified hypertensive heart disease
                                                            404                                                                                 Hypertensive heart and chronic kidney disease
                                                            404.02                                                                              Hypertensive heart and chronic kidney disease, malignant, without heart failure and with chronic kidney disease stage V or end stage renal disease
                                                            404.1                                                                               Benign hypertensive heart and renal disease
                                                            404.12                                                                              Hypertensive heart and chronic kidney disease, benign, without heart failure and with chronic kidney disease stage V or end stage renal disease
                                                            404.9                                                                               Unspecified hypertensive heart and renal disease
                                                            404.90                                                                              Hypertensive heart and chronic kidney disease, unspecified, without heart failure and with chronic kidney disease stage I through stage IV, or unspecified
                                                            404.92                                                                              Hypertensive heart and chronic kidney disease, unspecified, without heart failure and with chronic kidney disease stage V or end stage renal disease

ICD-9=*International Classification of Diseases, Ninth Revision*.

###### 

Diagnosis Codes for Adverse Events

  Event                         ICD-9^[a](#TFCU1-1){ref-type="table-fn"}^ Code                                                  Description
  ----------------------------- ----------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------
  Transient ischemic attack     435.8                                                                                           Other specified transient cerebral ischemia
  435.9                         Unspecified transient cerebral ischemia                                                         
  Cerebrovascular accident      430                                                                                             Subarachnoid hemorrhage
  431                           Intracerebral hemorrhage                                                                        
  432.0                         Nontraumatic extradural hemorrhage                                                              
  432.1                         Subdural hemorrhage                                                                             
  432.9                         Unspecified intracranial hemorrhage                                                             
  433.01                        Occlusion and stenosis, basilar artery, with cerebral infarction                                
  433.11                        Occlusion and stenosis, carotid artery, with cerebral infarction                                
  433.21                        Occlusion and stenosis, vertebral artery, with cerebral infarction                              
  433.31                        Occlusion and stenosis, multiple and bilateral precerebral arteries, with cerebral infarction   
  433.81                        Occlusion and stenosis, other specified precerebral artery, with cerebral infarction            
  433.91                        Occlusion and stenosis, unspecified precerebral artery, with cerebral infarction                
  434.01                        Cerebral thrombosis, with cerebral infarction                                                   
  434.11                        Cerebral embolism, with cerebral infarction                                                     
  434.91                        Cerebral artery occlusion, unspecified, with cerebral infarction                                
  997.02                        Iatrogenic cerebrovascular infarction or hemorrhage                                             
  Acute myocardial infarction   410.01                                                                                          Acute myocardial infarction, anterolateral wall
  410.11                        Acute myocardial infarction, other anterior wall                                                
  410.21                        Acute myocardial infarction, inferolateral wall                                                 
  410.31                        Acute myocardial infarction, inferoposterior wall                                               
  410.41                        Acute myocardial infarction, other inferior wall                                                
  410.51                        Acute myocardial infarction, other lateral wall                                                 
  410.61                        Acute myocardial infarction, true posterior wall                                                
  410.71                        Acute myocardial infarction, subendocardial (NSTEMI^[a](#TFCU1-1){ref-type="table-fn"}^)        
  410.81                        Acute myocardial infarction, other sites                                                        
  410.91                        Acute myocardial infarction, unspecified site                                                   
  Pneumothorax                  512.0                                                                                           Spontaneous tension pneumothorax
  512.1                         Iatrogenic pneumothorax                                                                         
  512.8                         Other spontaneous pneumothorax                                                                  
  Pulmonary embolism            415.1                                                                                           Pulmonary embolism and infarction
                                415.11                                                                                          Iatrogenic pulmonary embolism and infarction
                                415.12                                                                                          Septic pulmonary embolism
                                415.19                                                                                          Other pulmonary embolism and infarction
  Other embolism                453.4                                                                                           Acute venous embolism and thrombosis of deep vessels of lower extremity
                                453.41                                                                                          Acute venous embolism and thrombosis of deep vessels of proximal lower extremity
                                453.42                                                                                          Acute venous embolism and thrombosis of deep vessels of distal lower extremity
                                453.8                                                                                           Acute venous embolism and thrombosis of other specified veins
                                453.9                                                                                           Other venous embolism and thrombosis of unspecified site
  Operative complication        997.1                                                                                           Cardiac complications
                                997.2                                                                                           Peripheral vascular complications
                                997.3                                                                                           Respiratory complications
                                997.31                                                                                          Ventilator associated pneumonia
                                997.39                                                                                          Other respiratory complications
                                997.4                                                                                           Digestive system
                                997.5                                                                                           Urinary tract
                                997.7                                                                                           Vascular complications of other vessels
                                998                                                                                             Other complications of procedures
                                998.x                                                                                           Other complications of procedures
                                998.xx                                                                                          Other complications of procedures
  Other adverse events          997.4                                                                                           Digestive system complications
                                789.4x                                                                                          Abdominal rigidity/tenderness
                                789.6x                                                                                          Abdominal rigidity/tenderness
                                536.2                                                                                           Nausea and vomiting nausea
                                564.3                                                                                           Nausea and vomiting nausea
                                787.0x                                                                                          Nausea and vomiting nausea
                                536.3                                                                                           Gastroparesis paralytic ileus
                                560.1                                                                                           Gastroparesis paralytic ileus
                                567.9                                                                                           Peritonitis not specified
                                567.8x                                                                                          Peritonitis not specified
                                576.2                                                                                           Bile duct obstruction
                                576.3                                                                                           Bile duct perforation
                                576.4                                                                                           Bile duct fistula

ICD-9=*International Classification of Diseases, Ninth Revision*; NSTEMI=non--ST-segment elevation myocardial infarction.
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